Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/3/2025 | $79.00 | Equal-Weight → Overweight | Morgan Stanley |
| 6/3/2025 | $60.00 | Neutral → Buy | B. Riley Securities |
| 6/2/2025 | $51.00 | Neutral → Buy | BofA Securities |
| 5/20/2025 | $55.00 | Buy | Stifel |
| 3/13/2025 | $52.00 | Buy | Citigroup |
| 12/10/2024 | $60.00 | Buy | BTIG Research |
| 12/6/2024 | $55.00 | Market Perform | BMO Capital Markets |
| 12/2/2024 | $57.00 | Equal Weight → Overweight | Wells Fargo |
4 - Kymera Therapeutics, Inc. (0001815442) (Issuer)
4 - Kymera Therapeutics, Inc. (0001815442) (Issuer)